Searched for
MICAFUNGIN
Biocon arm gets Health Canada nod for fungal infection treatment injection- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 26% in 1 year
- Ignore noise on the street, stick to basics: 5 stocks from different sectors with an upside potential of up to 38%The markets are volatile with a bearish bias, and the Nifty and Sensex are bearing the brunt. A closer look, however, reveals that, even in...10 Oct, 2024, 05.00 AM IST
- Stocks in news: ZEE, M&M Financial, Dr Reddy's, Wipro, BioconDomestic markets rally on exit polls predicting Modi government's massive mandate. ZEE, M&M Financial, Dr Reddy's, Wipro, Biocon in focus. ...04 Jun, 2024, 07.34 AM IST
- For moderate risk takers: 5 midcap stocks from different sectors with potential upside of up to 36%Unlike last quarter of 2023, when nifty and sensex used to witness correction and mid-cap index was able move higher. Since the start of 20...15 Feb, 2024, 02.06 PM IST
- Getting back into shape? 6 Indian pharma stocks with upside potential of up to 41%The year 2024, started with a correction in nifty, but one set of stocks which were able to outperform were pharma stocks. While it might a...04 Jan, 2024, 02.09 PM IST
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%In the last few weeks, the range in which the nifty had been moving has become broader as the volatility has increased both due to internat...14 Nov, 2023, 11.46 AM IST
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside scope of over 20%As the market moves from clearly bullish mode to volatile mode with a bearish bias, there will be readjustment in valuation across markets....07 Nov, 2023, 01.02 PM IST
- These largecaps have ‘strong buy’ & ‘buy’ recos and upside potential of more than 20%While the correction has been going on in the market since the middle of July, it is only on days like Monday where everyone on the street ...25 Oct, 2023, 11.46 AM IST
- Next big delta in pharma to come from biosimilars: Nithya Balasubramanian“For Aurobindo Pharma, our official rating is market performance. We do not recommend it from a long-term perspective. It is only a tactica...28 Jun, 2023, 01.30 PM IST
- Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...19 May, 2023, 10.35 AM IST
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...10 May, 2023, 01.13 PM IST
- These largecaps have ‘Strong Buy’ & ‘Buy’ reco and upside potential of more than 25%As the NIFTY and broader market recovers, analysts are bullish on select large cap stock. Making to the list are a host of companies from d...02 May, 2023, 01.12 PM IST
- Should you stick to largecaps amid volatile Nifty? These 4 stocks have up to 30% upside scopeAs volatility increases, the focus in the market is shifting to stocks which are considered as relatively defensive. These stocks tend to f...09 Feb, 2023, 05.54 PM IST
- A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...17 Jan, 2023, 11.25 AM IST
- Stocks in the news: Hero Motocorp, Gland Pharma, SBI Cards, Dabur and DLFSBI Cards, Indus Towers, Tata Chemicals, REC, Aditya Birla Sun Life AMC, V-Guard Industries, Balaji Amines, Anupam Rasayan, TMB PNB Housing...27 Oct, 2022, 07.42 AM IST
- USFDA approves Zydus Lifesciences to market generic Micafungin injectionThe United States Food and Drug Administration (USFDA) has given its approval to market Micafungin for Injection, 50 mg/vial and 100 mg/via...26 Oct, 2022, 01.16 PM IST
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...03 Mar, 2022, 01.02 PM IST
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...05 May, 2008, 10.08 PM IST
Load More
